14.01.2013 Views

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

Visit our Expo - Redox and Inflammation signaling 2012

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Session III : Protein kinase cascades as therapeutic targets Poster III, 14<br />

MAPK pathways influence the release of .NO <strong>and</strong> PGE2 in IL-1# stimulated<br />

chondrocyte/agarose constructs subjected to dynamic compression<br />

T T Chowdhury, K Elliot*, D M Salter*, D L Bader <strong>and</strong> D A Lee<br />

Queen Mary, University of London, Mile End Road, London. E1 4NS. UK<br />

*Edinburgh University Medical School, Edinburgh. EH16 4TJ<br />

E-mail : t.t.chowdhury@qmul.ac.uk<br />

Introduction: Nitric oxide (.NO) <strong>and</strong> prostagl<strong>and</strong>in E2 (PGE2) are catabolic mediators<br />

induced by IL-1# <strong>and</strong> are therefore potentially important pharmacological targets in<br />

osteoarthritis (OA). In chondrocytes, the application of mechanical load has been shown to<br />

counteract the IL-1# induced .NO <strong>and</strong> PGE2 release. Furthermore, the cytokine can activate<br />

all three members of the MAPK family. However, the role of the MAPK subtypes in the<br />

release of .NO <strong>and</strong> PGE2 in chondrocytes is complex <strong>and</strong> may primarily involve<br />

phosphorylation of p38 or JNK <strong>and</strong> activation of NF!B <strong>and</strong> AP-1. The current study<br />

examines whether inhibition of these pathways will abolish the IL-1# induced .NO <strong>and</strong> PGE2<br />

release in mechanically stimulated chondrocyte/agarose constructs.<br />

Methods: Bovine chondrocytes seeded in agarose gel were cultured under free-swelling<br />

conditions, for 48 hrs in medium containing 0 or 10 ng.ml-1 IL-1#, supplemented with 0 to<br />

1000 ng.ml-1 SB203580 (inhibitor of p38 MAPK) or 0 to 50 nM JNK II (inhibitor of JNK-1,<br />

2, 3), or 0 to 1000 ng.ml-1 PDTC (inhibits NFkB activation) or 0 to 1000 ng.ml-1 curcumin<br />

(inhibitor of AP-1). For the mechanical loading experiments, all constructs were subjected to<br />

15 % dynamic compression (1 Hz) for 48 hrs under the following conditions: 0 or 10 ng.ml-1<br />

IL-1#, +/- 10 ng.ml-1 SB203580 or 5 nM JNK II or 10 ng.ml-1 PDTC or 10 ng.ml-1<br />

curcumin.<br />

Results: For constructs cultured under free-swelling conditions, SB203580 <strong>and</strong> JNK II<br />

resulted in a dose-dependent inhibition of nitrite <strong>and</strong> PGE2 release in IL-1# stimulated<br />

constructs. PDTC <strong>and</strong> curcumin reversed the IL-1# induced nitrite release whereas PGE2<br />

levels were only partially inhibited. For the mechanical loading experiments, dynamic<br />

compression could counteract the IL-1# induced nitrite release. Compression-induced<br />

inhibition of nitrite release was abolished by SB203580, PDTC <strong>and</strong> curcumin <strong>and</strong> partially<br />

reduced by JNK II. The application of dynamic compression resulted in the strain-induced<br />

inhibition of PGE2 release in IL-1# stimulated constructs. This effect was abolished by<br />

SB203580 <strong>and</strong> JNK II <strong>and</strong> partially reduced by PDTC <strong>and</strong> curcumin.<br />

Discussion: These results suggest the involvement of MAPKs <strong>and</strong> the transcription factors,<br />

AP-1 <strong>and</strong> NFkB in the IL-1# induced release of .NO <strong>and</strong> PGE2. Further work will determine<br />

the sequential activation of the signalling cascades associated with mechanical load <strong>and</strong> IL-<br />

1#. Moreover, the temporal organization of the multiple pathways will provide important<br />

information for the pharmacological <strong>and</strong> biophysical treatment of degenerative joint disease<br />

as observed in OA.<br />

Acknowledgements:<br />

This work was supported by a project grant from the Wellcome Trust, project number,<br />

073972<br />

- 197 -

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!